Key Market Indicator:
Stock market news: In short news style a la Twitter/X. Everything that is relevant - at a glance. The entry page for the informed investor. Compact, worth knowing and always up to date. Directly from the IR departments of the companies.
Tue, 01.04.2025
TAKKT AG
TAKKT CFO Lars Bolscho will not extend his contract
Stuttgart, Germany, April 1, 2025. Lars Bolscho, CFO of TAKKT AG, informed the TAKKT Supervisory Board in March of his decision not to seek an extension of his contract, which runs until the end of 2025. “My decision is the result of careful consideration. After more than fifteen years with the [ … ]
Tue, 01.04.2025
Gurit Holding AG
Gurit Holding AG
/ Key word(s): Contract
GURIT COMPLETES THE DIVESTMENT OF CARMIGNANO DI BRENTA SITE IN ITALY
01.04.2025 / 17:40 CET/CEST
Zurich, April 1, 2025
Gurit (SIX Swiss Exchange: GURN) confirms today the closing of the divestment of its PET recycling site in Carmignano di Brenta, Italy, as part of its ongoing s [ … ]
Tue, 01.04.2025
Oldenburgische Landesbank AG
PRESS-RELEASE
Oldenburg, 1 April 2025
OLB: Changes in the Supervisory Board
Shareholders appoint four new members
John Denhof replaces Axel Bartsch as Chairman of the Supervisory Board
The shareholders of Oldenburgische Landesbank AG ("OLB" or "Bank") have appointed new representatives of their side to the Bank's Supervisory Board. John De [ … ]
Tue, 01.04.2025
M1 Kliniken AG
M1 Kliniken AG: HAEMATO AG is reviewing an offer for the sale of its trading segment
HAEMATO AG, which is majority-owned by M1 Kliniken AG, has received a so-called Conditional Binding Offer (CBO) for the acquisition of its trading segment, the wholly-owned subsidiary HAEMATO PHARM GmbH. The Executive Board and Supervisory Board of HAEMATO AG are c [ … ]
Tue, 01.04.2025
Lisata Therapeutics Inc
Company Name:
Lisata Therapeutics Inc
ISIN:
US1280583022
Reason for the research:
Update
Recommendation:
Buy
from:
01.04.2025
Target price:
USD 15.00
Target price on sight of:
12 months
Last rating change:
-
Analyst:
Christian Orquera
First Berlin Equity Research has published a research update on Lisata Therapeutics, Inc. (IS [ … ]
Tue, 01.04.2025
SYNBIOTIC SE
SYNBIOTIC presents medical cannabis as a pastille for the German market for the first time
SYNBIOTIC SE (ISIN DE000A3E5A59 | WKN A3E5A5), the European group of companies specialising in medical cannabis and industrial hemp, is launching medical cannabis pastilles on the German market for the first time during the second quarter. The pastille formul [ … ]
Tue, 01.04.2025
OC Oerlikon
OC Oerlikon
/ Key word(s): AGMEGM
Shareholders approved all resolutions 01.04.2025 / 15:01 CET/CEST
Dividend payout of CHF 0.20 per share was approved
Prof. Dr. Michael Suess was re-elected as Chairman of the Board
All Board Members who stood for re-election were voted in
Stefan Brupbacher, Marco Musetti and Eveline Steinb [ … ]
Tue, 01.04.2025
ADS-TEC Energy GmbH
Q8 selects ADS-TEC Energy and orders more than a dozen battery-based fast-charging systems.
Roll-out of charging infrastructure in Belgium and the Netherlands with ADS-TEC Energy's all-in-one solution ChargePost and ChargeBox.
ADS-TEC Energy enables ultra-fast charging at gas stations even at locations with limited grid capacity.
NÜRTINGEN, Ge [ … ]
Tue, 01.04.2025
Mainz BioMed N.V.
Mainz Biomed Reports 2024 Financial Results and Provides Corporate Update
Lab network revenue increased by 33% year over year, reflecting strong demand for ColoAlert® in Europe
Operating loss decreased by 30% and net loss by 18%, driven by targeted cost reductions and a sharper strategic focus
Strategic partnerships with industry leaders mark ke [ … ]
Tue, 01.04.2025
Lonza Group AG
Lonza Group AG
/ Key word(s): Miscellaneous
Lonza Implements its Simplified and Streamlined Operating Model 01.04.2025 / 14:00 CET/CEST
Lonza’s new simplified and streamlined operating model is designed to support its One Lonza vision and strategy
Previous divisional structure is now replaced with three newly formed CDMO Bus [ … ]